MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
936.14%
Quick Ratio
936.14%
Cash Ratio
43.21%
Debt to Asset Ratio
20.76%
Unit: Thousand (K) dollars
Assets Breakdown
Total current assets
Operating lease right-of-use ass...
Property and equipment, net
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Deferred revenue, net of current...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
17,224
28,828
12,667
34,185
Short-term investments
313,056
317,879
124,385
109,441
Restricted cash
917
-
-
-
Accounts receivable
37,494
646
2,013
1,629
Prepaid expenses and other current assets
4,464
5,743
4,856
3,962
Total current assets
373,155
353,096
143,921
149,217
Property and equipment, net
1,079
1,090
1,304
1,721
Intangible assets, net
365
401
438
474
Goodwill
949
949
949
949
Restricted cash
610
1,527
1,527
1,028
Operating lease right-of-use asset
5,037
2,264
3,396
4,814
Other assets
31
31
31
51
Total assets
381,226
359,358
151,566
158,254
Accounts payable
1,939
1,368
1,301
646
Accrued liabilities
12,353
11,923
14,197
12,408
Operating lease liabilities - short term
1,496
2,856
4,240
5,596
Deferred revenue, current portion
24,073
17,876
26,877
22,379
Total current liabilities
39,861
34,023
46,615
41,029
Deferred revenue, net of current portion
30,617
979
1,590
5,537
Operating lease liabilities - long term
4,208
-
0
0
Other long-term liabilities
4,472
4,412
4,353
4,299
Total liabilities
79,158
39,414
52,558
50,865
Convertible preferred stock
0
0
-
0
Common stock
2
2
2
2
Additional paid-in capital
1,053,125
1,050,037
810,844
789,720
Accumulated other comprehensive income
-196
102
111
104
Accumulated deficit
-750,863
-730,197
-711,949
-682,437
Total stockholders' equity
302,068
319,944
99,008
107,389
Total liabilities and stockholders' equity
381,226
359,358
151,566
158,254
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Short-term investments
$313,056K
(187.09%↑ Y/Y)
Accounts receivable
$37,494K
(1906.10%↑ Y/Y)
Cash and cash
equivalents
$17,224K
(-64.88%↓ Y/Y)
Prepaid expenses and
other current assets
$4,464K
(-4.31%↓ Y/Y)
Restricted cash
$917K
(-10.80%↓ Y/Y)
Total current assets
$373,155K
(126.68%↑ Y/Y)
Operating lease
right-of-use asset
$5,037K
(-15.30%↓ Y/Y)
Property and equipment,
net
$1,079K
(-44.55%↓ Y/Y)
Goodwill
$949K
(0.00%↑ Y/Y)
Restricted cash
$610K
(-40.66%↓ Y/Y)
Intangible assets, net
$365K
(-28.43%↓ Y/Y)
Other assets
$31K
(-44.64%↓ Y/Y)
Total assets
$381,226K
(117.77%↑ Y/Y)
Total liabilities and
stockholders' equity
$381,226K
(117.77%↑ Y/Y)
Total stockholders'
equity
$302,068K
(151.91%↑ Y/Y)
Total liabilities
$79,158K
(43.54%↑ Y/Y)
Accumulated deficit
-$750,863K
(-12.37%↓ Y/Y)
Accumulated other
comprehensive income
-$196K
(-693.94%↓ Y/Y)
Additional paid-in capital
$1,053,125K
(33.63%↑ Y/Y)
Total current
liabilities
$39,861K
(1.63%↑ Y/Y)
Deferred revenue, net of
current portion
$30,617K
(198.96%↑ Y/Y)
Other long-term
liabilities
$4,472K
(5.45%↑ Y/Y)
Operating lease
liabilities - long term
$4,208K
(191.82%↑ Y/Y)
Common stock
$2K
(0.00%↑ Y/Y)
Deferred revenue,
current portion
$24,073K
(9.17%↑ Y/Y)
Accrued liabilities
$12,353K
(7.39%↑ Y/Y)
Accounts payable
$1,939K
(754.19%↑ Y/Y)
Operating lease
liabilities - short term
$1,496K
(-72.52%↓ Y/Y)
Buy us a coffee
CytomX Therapeutics, Inc. (CTMX)
CytomX Therapeutics, Inc. (CTMX)